Episodio – Abacavir y el alelo HLA-B*57:01: hipersensibilidad potencialmente fatal | USMLE Step 1 episode artwork

EPISODE · Nov 17, 2025 · 5 MIN

Episodio – Abacavir y el alelo HLA-B*57:01: hipersensibilidad potencialmente fatal | USMLE Step 1

from USMLE DREAMERS · host USMLE DREAMERS

Paciente con HIV (human immunodeficiency virus) necesita reiniciar terapia antirretroviral, pero tiene resultado positivo para el alelo HLA-B*57:01. Explicamos por qué abacavir está contraindicado, el mecanismo inmunológico de esta reacción tipo IV, y cómo identificarla clínicamente. Un tema clásico de farmacología e inmunología en el Step 1.#USMLE #Step1 #USMLEDreamers #HIV #Abacavir #HLAB5701 #NRTI #Hypersensitivity

Episode metadata supplied by the publisher feed · Published Nov 17, 2025

Embed this episode

Ready to play

Episodio – Abacavir y el alelo HLA-B*57:01: hipersensibilidad potencialmente fatal | USMLE Step 1

0:00 5:16

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of USMLE DREAMERS?

This episode is 5 minutes long.

When was this USMLE DREAMERS episode published?

This episode was published on November 17, 2025.

Can I download this USMLE DREAMERS episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!